Author

Zafar Iqbal

University of the PunjabORCID 0000-0002-1334-6372Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Assay:whole-exome sequencing· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Assay:metabolomics· 1

Frequent Co-Authors

Amer MahmoodiD· 3 shared Masood A. ShammasiD· 3 shared Sarah AlMukhaylidiD· 3 shared Abdulaziz Siyal· 2 shared Nawaf AlanaziiD· 2 shared Aamer AleemiD· 1 shared Aamir Aleem· 1 shared Abdulkareem Al-GarniiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Amer MahmoodORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJul 29, 2025

Multi-Omics and AI-/ML-Driven Integration of Nutrition and Metabolism in Cancer: A Systematic Review, Meta-Analysis, and Translational Algorithm

Zafar Iqbal, Lubna Alnuaim, Abdulkareem Al-Garni…·Giuseppe Nicola Saglio

This paper reviews and analyzes how multi-omics and AI/ML approaches integrate nutrition and metabolism in cancer, showing strong diagnostic and predictive capabilities and proposing a clinical algorithm for low-resource settings.

7 citations

humanmetabolomics

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintMar 9, 2024

A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, SALMAN ABDUL BASIT…·Zafar Iqbal

This study validates ZNF208 mutation (c.64G>A) as a specific biomarker for advanced phase CML through targeted resequencing in a case-control cohort.

DOI 10.1101/2024.03.09.24304026

humanDNA methylation

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintDec 19, 2023

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar…·Zafar Iqbal

This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.

DOI 10.1101/2023.12.19.23300103

humanwhole-exome sequencing

𝕏 PostBluesky